Condition Deep-Dives 11 min read·Updated 22 July 2026 Clinician-reviewed

Aristolochic Acid Nephropathy

A UK Consultant Nephrologist on aristolochic acid nephropathy — the herbal poisoning that progresses to CKD and a markedly raised risk of upper-tract urothelial cancer, and why MHRA banned aristolochia-containing remedies in 2001.

  • Clinically Reviewed
  • NHS & NICE Aligned
  • UK Evidence-Based
  • Last Reviewed 22 July 2026

Professor Mohammed Mahdi Althaf

Consultant Nephrologist & Acute Physician

View Credentials

Professor Mohammed Mahdi Althaf

MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN

Consultant Nephrologist & Acute Physician · GMC 7216325

View profile →

Direct answer

Aristolochic acid is nephrotoxic AND a powerful urothelial carcinogen. Causes progressive interstitial fibrosis, small shrunken kidneys, and ~ 40% lifetime risk of upper-tract urothelial cancer. Stop exposure, manage CKD, and screen the urothelium for life. MHRA-banned in the UK since 2001.

Key recommendation: Found in Aristolochia and Asarum herbal medicines.

Quick answer

✓ Best choices

  • Vegetables, lower-potassium fruit and whole grains
  • Sensible portions of fish, eggs, chicken or tofu
  • Olive oil and unsalted nuts in small amounts

✓ Foods to limit

  • Added salt and ultra-processed foods
  • Phosphate additives in processed meats and ready meals
  • Sugary and energy drinks

Key takeaway

Aristolochic acid is nephrotoxic AND a powerful urothelial carcinogen. Causes progressive interstitial fibrosis, small shrunken kidneys, and ~ 40% lifetime risk of upper-tract urothelial cancer. Stop exposure, manage CKD, and screen the urothelium for life. MHRA-banned in the UK since 2001.

Who should be cautious

People on dialysis, post-transplant, pregnant or breastfeeding, or taking prescription medication — confirm with your renal team before changes.

Aristolochic Acid Nephropathy

Sources, mechanism & UK regulation

Sources Of Aa

  • Aristolochia fangchi, A. clematitis, A. manshuriensis — historically widely used in Traditional Chinese Medicine (Mu Tong, Guang Fang Ji)
  • Asarum europaeum, A. canadense (wild ginger)
  • Contamination of wheat grain in rural Balkans (A. clematitis weed)
  • Some Ayurvedic and folk remedies still contain AA outside regulated markets
  • Online slimming, 'detox', anti-inflammatory and 'kidney support' herbal preparations

Mechanism

  • AA metabolised to aristolactam → forms DNA adducts (dA-AL-I)
  • A→T transversion mutations — signature mutation in p53 and FGFR3
  • Direct proximal tubular toxicity → tubular atrophy, hypocellular interstitial fibrosis
  • Urothelial carcinogenesis throughout collecting system → bilateral, multifocal cancers

UK Regulation

  • Medicines Act 1968 + MHRA — all aristolochia-containing herbal products PROHIBITED since 2001
  • Still imported and consumed outside regulation — patients may be unaware
  • EU and WHO list AA as Group 1 human carcinogen
  • Patient enquiry MUST include all herbal, traditional, online and overseas medications

Clinical features & diagnosis

Presentation

  • Insidious progressive CKD — months to years after exposure
  • Mild proteinuria (< 1.5 g/day; tubular pattern)
  • Bland sediment ± sterile pyuria
  • Glycosuria, aminoaciduria (Fanconi-like)
  • Normocytic anaemia disproportionate to CKD stage
  • Hypertension late
  • Painless haematuria → think urothelial cancer

Imaging

  • Small, smooth, shrunken kidneys (asymmetric possible)
  • Cortical thinning
  • CT urography: assess upper urinary tract for filling defects

BIOPSY (if performed):

  • Hypocellular interstitial fibrosis (PALE pink on H&E)
  • Tubular atrophy with brush-border loss
  • Relative sparing of glomeruli early
  • Negative immunofluorescence
  • Differential: chronic TIN of other cause, ischaemic nephropathy, ADTKD

Definitive

  • AA-DNA adducts in renal/urothelial tissue — specialist centres (32P-postlabelling, LC-MS)
  • Signature A→T transversions on tumour sequencing if cancer arises

Clinical Clue

  • Always ask explicitly about herbal, traditional, slimming and 'detox' preparations
  • Travel and ethnic-origin context useful

Management & cancer surveillance

Stop Exposure

  • Discontinue all aristolochia-containing herbals immediately
  • Report to MHRA Yellow Card
  • Identify and treat other exposed family members or community contacts

CKD Care

  • BP target < 130/80
  • ACE-i / ARB (titrate)
  • SGLT2 inhibitor if eGFR > 20
  • Statin
  • CKD bone, anaemia management
  • Avoid further nephrotoxins
  • Vaccinations
  • Plan for renal replacement therapy as needed

Urothelial Cancer Surveillance (Lifelong)

  • Annual urine cytology
  • Annual CT urography (alternate with MR urography to limit contrast/radiation)
  • Investigate any haematuria promptly with cystoscopy ± ureteroscopy
  • ~ 40% lifetime risk in heavily exposed (Belgian Aristolochia cohort)
  • Tumours commonly multifocal and bilateral

Transplant Considerations

  • Wait until off immunosuppression-amplified cancer risk is acceptable
  • Consider PROPHYLACTIC BILATERAL NEPHROURETERECTOMY at the time of transplant — removes carcinogenic native urothelium
  • Lifelong post-transplant surveillance still required
  • Living donor preferred where possible

Research/experimental

  • Antioxidant strategies under study; nothing established
  • Anti-fibrotic agents not yet evidence-based
Lithium Nephrotoxicity
Related reading: Lithium Nephrotoxicity.

Key practical tips

Designed for quick scanning — what to order, what to avoid, sensible portions, common mistakes.

  • Cook from scratch when you can
  • Read sodium labels (≤ 0.3 g per 100 g is low)
  • Take any concerns to your GP or renal team early

Clinical guidance

TL;DR summary

Aristolochic acid is nephrotoxic AND a powerful urothelial carcinogen. Causes progressive interstitial fibrosis, small shrunken kidneys, and ~ 40% lifetime risk of upper-tract urothelial cancer. Stop exposure, manage CKD, and screen the urothelium for life. MHRA-banned in the UK since 2001.

Key takeaways
  • Found in Aristolochia and Asarum herbal medicines.
  • Cause of Balkan endemic nephropathy.
  • Small shrunken kidneys + bland sediment.
  • Massive upper-tract urothelial cancer risk.
  • MHRA-banned in UK since 2001.
Kidney Diet & Nutrition Considerations

Diet is one of the most powerful tools you have to look after your kidneys. UK renal guidance points to a Mediterranean-style, reduced-salt pattern: plenty of vegetables, lower-potassium fruit, whole grains, sensible protein, beans and pulses in moderation, oily fish and olive oil. Personal targets — for potassium, phosphate, protein and fluid — should be set by your renal team based on your bloods.

Foods to prioritise

  • Vegetables, lower-potassium fruit and whole grains
  • Sensible portions of fish, eggs, chicken or tofu
  • Olive oil and unsalted nuts in small amounts

Foods to limit

  • Added salt and ultra-processed foods
  • Phosphate additives in processed meats and ready meals
  • Sugary and energy drinks

Potassium, phosphate and protein needs vary between individuals — please confirm personal targets with your renal team or dietitian. Browse the Kidney Diet Hub for more guides in this cluster.

Frequently asked questions

What is aristolochic acid nephropathy?

Aristolochic acid nephropathy (AAN) is a progressive interstitial fibrosis caused by chronic exposure to aristolochic acid (AA) — a nephrotoxic and carcinogenic alkaloid found in Aristolochia and Asarum plant species. Originally described as 'Chinese herb nephropathy' in Belgian women who took a slimming preparation containing Aristolochia fangchi in the 1990s, and now recognised as the cause of Balkan endemic nephropathy from contamination of grain in rural Balkan villages.

How does it present?

Slowly progressive CKD with bland urinary sediment, sterile pyuria, modest proteinuria (usually < 1.5 g/day) and small, shrunken kidneys on imaging. Patients may have mild Fanconi-like features (glycosuria, aminoaciduria). Most importantly, AA is a powerful urothelial carcinogen — patients have a markedly increased risk (~ 40% lifetime in heavily exposed cohorts) of upper-tract urothelial carcinoma (renal pelvis, ureter) which can be multifocal and bilateral.

How is it diagnosed?

Clinical: appropriate history of herbal preparation use (slimming, traditional Chinese, Ayurvedic), Balkan village residence, or unexplained progressive CKD in someone with the above. Imaging: small, smooth, shrunken kidneys. Biopsy: hypocellular interstitial fibrosis with relative sparing of glomeruli, tubular atrophy and prominent tubular brush border loss. Definitive: AA-DNA adducts in renal/urothelial tissue (research/specialist centres). MHRA in the UK has banned all herbal medicines containing aristolochia since 2001.

What is the treatment?

STOP all aristolochia-containing herbal products immediately. There is no specific antidote. Standard CKD management: BP control with ACE-i/ARB, SGLT2i if eGFR > 20, statin, vaccinations, planning for renal replacement. Lifelong surveillance for upper-tract urothelial carcinoma — annual urine cytology + CT urography (or MR urography). Prophylactic nephroureterectomy of the native kidneys is considered at the time of any kidney transplant in heavily exposed patients to remove the carcinogenic urothelium.

What foods are good for kidney health?

A Mediterranean-style, mostly plant-based, reduced-salt diet is the most consistent evidence-based pattern for kidney health. Build meals around vegetables, lower-potassium fruit, whole grains, fish, eggs or tofu, beans and pulses in moderation, and olive oil.

Nutritional challenges in kidney disease

Many people living with kidney disease have to limit foods because of potassium, phosphate, diabetes, dialysis, appetite changes or simply the time it takes to cook from scratch every day. That can make it harder to keep daily nutrition balanced — particularly for vitamins and minerals that food alone may not fully cover.

Kidney Vitality is a UK-formulated daily nutritional support product designed by Consultant Nephrologist Professor Mohammed Mahdi Althaf with renal nutrition in mind from the start. It keeps doses moderate, leaves out added potassium, phosphate and magnesium, and avoids megadose vitamin A — sitting alongside a kidney-friendly diet, not replacing it.

Why Kidney Vitality fits this need

Built around UK guidance

Aligned with MHRA herbal medicines guidance, NICE NG203 chronic kidney disease, BAUS urology and EAU upper-tract urothelial carcinoma guidelines, and KDIGO 2024 CKD evaluation.

Designed by a UK Consultant Nephrologist

Formulated and reviewed by Professor Mohammed Mahdi Althaf (GMC 7216325).

Carcinogen-aware & UK-regulated

Practical guidance on cause-specific history-taking, MHRA reporting and lifelong upper-tract cancer surveillance.

Designed by a UK Consultant Nephrologist

Ready to support your kidney health?

If you have been researching kidney health, supplements, CKD nutrition or kidney-friendly living, Kidney Vitality was developed specifically around those principles by Professor Mohammed Mahdi Althaf (GMC 7216325). Nephrologist Developed Daily Multivitamin.

  • No Added Potassium
  • No Added Magnesium
  • No Added Phosphorus
  • No Added Iron
  • One capsule daily
  • UK GMP — BRCGS, NSF GMP, Halal
Subscribe & Save — £20.39/monthCheck your current multivitamin

✓ Free UK tracked delivery  ·  ✓ Delivered every 30 days  ·  ✓ Pause or cancel anytime  ·  ✓ Never run out

ComparisonKidney VitalityTypical high-street multivitamin
Added potassiumNoneOften included
Added phosphateNoneOften included (E338–E452)
Vitamin A (retinol)No megadoseOften high-dose retinol
Kidney-focused formulationYesNo — general population
Consultant Nephrologist involvementYes (GMC 7216325)No
UK GMP manufacturedYes (BRCGS, NSF GMP)Varies

Food supplement. Not a medicine and not a treatment for kidney disease. Speak with your GP, pharmacist or renal team before starting any new supplement, especially in advanced CKD, on dialysis, post-transplant, pregnant or breastfeeding.

Clinical reviewer

Professor Mohammed Mahdi Althaf

Consultant Nephrologist

Acute Physician

GMC 7216325

View Full Biography

Professor Mohammed Mahdi Althaf is a UK Consultant Nephrologist and Acute Physician with a special interest in chronic kidney disease, AKI prevention and renal nutrition. He combines hospital practice with patient education and clinical guidance review.

View professional profile →
View Credentials
  • MD
  • MSc
  • PgDip (Clin Ed)
  • FRCP
  • FHEA
  • FASN

About this article

Written for UK patients and based on:

  • NICE guidance
  • NHS resources
  • British Dietetic Association guidance
  • Kidney Care UK resources
View methodology

Each article is researched against current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO and KDOQI international guidelines, and the British Dietetic Association Renal Nutrition Group. Drafts are written by the Kidney Vitality editorial team and reviewed by a UK Consultant Nephrologist before publication. Content is reviewed on a rolling basis and updated when guidance changes.

Editorial standards

  • Clinically reviewed
  • NHS-aligned
  • NICE-aligned
  • Evidence-based
  • Reviewed before publication
View full editorial process

Every article is researched and written by the Kidney Vitality editorial team using current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO/KDOQI international guidelines, and British Dietetic Association renal nutrition guidance. Drafts are reviewed for clinical accuracy by Professor Mohammed Mahdi Althaf, MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN (Consultant Nephrologist & Acute Physician, GMC 7216325) before publication. Content is updated when UK guidance changes.

References (4)View Sources
  1. NICE NG203: Chronic kidney disease — assessment and management
  2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
  3. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update
  4. British Dietetic Association — Renal Nutrition Group

Medical disclaimer

This content is educational only and does not replace personalised medical advice.

Read full disclaimer

This page is general information, not personal medical advice. If you have chronic kidney disease, are on dialysis, have had a kidney transplant, are pregnant or breastfeeding, or take prescription medication, please confirm any supplement with your GP, pharmacist or renal team before starting.

← Back to all guides